HCM Academy is an independent educational initiative supported by grant funding from Bristol Myers Squibb, Cytokinetics, iRhythm Technologies, Sanofi and Tenaya Therapeutics. PCM Scientific is the organiser and all content is created by the faculty. No funder has had input into any content or activity.

Abstract Library

Abstract library - treatment and management

Treatment of HCM varies depending on disease characteristics, with management depending on stage and subtype of HCM. By looking at the prognostic outcomes of screening and diagnosis tests, these results are then used to direct and determine the most appropriate course of management and treatment on a case-by-case, individualized patient basis.